Extrait

To provide confidence in the safety of LTG, as measured by the incidence of rash (including SJS and any other serious drug eruption) in the first 8 weeks of treatment, in Japanese patients with epilepsy when administered at the same starting doses and with the same dose escalation method as recommended overseas for patients taking VPA.

Critère d'inclusion

• Epilepsy

Liens

• euctr